51 – 60 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)
(
- Contribution to journal › Article
- 2005
-
Mark
Activation recovery time measurements in evaluation of global sequence and dispersion of ventricular repolarization
(
- Contribution to journal › Article
-
Mark
Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Can Orthogonal Lead Indicators of Propensity to Atrial Fibrillation be Accurately Assessed from the 12-Lead ECG?
(
- Contribution to journal › Article
-
Mark
In vivo validation of the coincidence of the peak and end of the T wave with full repolarization of the epicardium and endocardium in swine.
(
- Contribution to journal › Article
-
Mark
Prevention of stroke in patients with atrial fibrillation.
(
- Contribution to journal › Article
-
Mark
Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram
(
- Contribution to journal › Article
-
Mark
T(peak)-T(end) Interval as an Index of Global Dispersion of Ventricular Repolarization: Evaluations Using Monophasic Action Potential Mapping of the Epi- and Endocardium in Swine.
(
- Contribution to journal › Article
-
Mark
QT dispersion failed to estimate the global dispersion of ventricular repolarization measured using monophasic action potential mapping technique in swine and patients
(
- Contribution to journal › Article
-
Mark
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation - A Randomized trial
(
- Contribution to journal › Article